Joshua M. Lang
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Biomedical Engineering top 10%
- Co-authors
- David J. BeebeDouglas G. McNeelTimothy KruegerGlenn LiuMarı́a Virumbrales-MuñozJosé M. AyusoScott M. BerryJamie M. Sperger
- Topics
- Prostate Cancer Treatment and Research (45 papers)Cancer Genomics and Diagnostics (28 papers)Cancer Cells and Metastasis (24 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesCanadaChina
In The Last Decade
Joshua M. Lang
123 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 1.0k
- Molecular Biology 822
- Pulmonary and Respiratory Medicine 585
- Immunology 497
- Biomedical Engineering 423
Countries citing papers authored by Joshua M. Lang
This map shows the geographic impact of Joshua M. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua M. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua M. Lang more than expected).
Fields of papers citing papers by Joshua M. Lang
This network shows the impact of papers produced by Joshua M. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua M. Lang. The network helps show where Joshua M. Lang may publish in the future.
Co-authorship network of co-authors of Joshua M. Lang
This figure shows the co-authorship network connecting the top 25 collaborators of Joshua M. Lang. A scholar is included among the top collaborators of Joshua M. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua M. Lang. Joshua M. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 9 | |
| 11 | 21 | |
| 12 | 1 | |
| 13 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinomabreakdown → | 223 |
| 14 | 1 | |
| 15 | 117 | |
| 16 | 50 | |
| 17 | 55 | |
| 18 | 20 | |
| 19 | 44 | |
| 20 | 114 |
About Joshua M. Lang
Joshua M. Lang is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 137 papers that have together received 2.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (45 papers), Cancer Genomics and Diagnostics (28 papers) and Cancer Cells and Metastasis (24 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (497 citations) and Cancer Research (339 citations). Joshua M. Lang has collaborated with scholars based in United States, Canada and China. Frequent co-authors include David J. Beebe, Douglas G. McNeel, Timothy Krueger, Glenn Liu, Marı́a Virumbrales-Muñoz, José M. Ayuso, Scott M. Berry, Jamie M. Sperger, Benjamin P. Casavant and Jens C. Eickhoff. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.